SEP 8, 2026 · JOURNAL ARTICLE
CRISPR-Cas13 RNA-Targeting Therapeutics for Achieving Functional HIV Remission in ReservoirContaining Tissues
Idosr Journal of Applied Sciences
A narrative review of preclinical and mechanistic studies proposing CRISPR-Cas13 as a therapeutic concept for HIV remission, without clinical trial data or definitive evidence of durable clinical benefit.
Hypothesis-GeneratingRNA Interference and Gene DeliveryCRISPR and Genetic EngineeringMukisa Ian Mugaiga
Reported
Global HIV burden40.8 million people living with HIV as of 2…